Although for many years the mechanism by which Aβ recruits tau to the disease process has remained a significant knowledge gap in the AD field [61], a recent study from our laboratory has identified a candidate mechanism which will be discussed later in this review. This evidence concerns the gene MAPT and Alzheimer disease.